Results 111 to 120 of about 65,798 (270)
Background Autoimmune hemolytic anemia is a rare condition in children. Little is known about its initial presentation and the subsequent progression of the disease.Design and Methods Since 2004, a national observational study has been aiming to ...
Nathalie Aladjidi +19 more
doaj +1 more source
Severe Autoimmune Hemolytic Anemia in COVID-19 İnfection, Safely Treated with Steroids
xx
F. Hindilerden +4 more
semanticscholar +1 more source
A constant rate of DNA damage that is not perfectly repaired will cause a constant rate of DNA mutations. The chance of mutation will increase if DNA is prone to damage, such as occurs in somatic hypermutation (SHM) hotspots and GC‐rich DNA. Thus, if one mutation‐prone DNA site drives disease, the age of onset of disease and degree of penetrance should
Piet C. de Groen
wiley +1 more source
Finding the elusive and causative autoantibody: An atypical case of autoimmune hemolytic anemia [PDF]
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/111227/1/ccr3203 ...
Clark D. A. +3 more
core +1 more source
Autoimmune hemolytic anemia (AIHA) is characterized by shortening of red blood cell (RBC) survival and the presence of autoantibodies directed against autologous RBCs.
Behzad Nazel Khosroshahi +5 more
doaj
ABSTRACT Aims/Introduction This study aimed to identify clinical predictors associated with sustained decline in estimated glomerular filtration rate (eGFR) among Japanese individuals diagnosed with diabetes mellitus. Materials and Methods We conducted a retrospective analysis using J‐DREAMS (Japan Diabetes compREhensive database project based on an ...
Kota Yamada +5 more
wiley +1 more source
Management of autoimmune hemolytic anemia in children and adolescents: A single center experience [PDF]
Objective: To present and discuss the treatment of autoimmune hemolytic anemia (AIHA). Materials and Methods: The medical records of all patients (n=19) diagnosed in a tertiary hematology center between 1999 and 2010 were retrospectively reviewed.Results:
Emine Zengin +3 more
core
Kaposi's sarcoma in a patient with erythroblastopenia and thymoma: Reactivation after topical corticosteroids [PDF]
We report a 69-year-old female with erythroblastopenia and thymoma who developed lesions of Kaposi's sarcoma (KS) after thymectomy, 2 months after the initiation of therapy with methylprednisolone.
Alomar, A. +8 more
core +1 more source

